Fosmanogepix. GPI-anchored wall transfer protein 1 (Gwt1) (fungal) inhibitor, Treatment of invasive fungal infections

enthalten in: Drugs of the future | 2021

von Thakare, R. | Dasgupta, A. | Chopra, S.

Rezafungin acetate. 1,3-beta-Glucan synthase inhibitor, Antifungal agent

enthalten in: Drugs of the future | 2020

von Chopra, S. | Thakare, R. | Dasgupta, A.

Exebacase. Bacteriophage-derived antistaphylococcal lysin, Direct lytic agent, Treatment of S. aureus bacteremia

enthalten in: Drugs of the future | 2020

von Thakare, R. | Dasgupta, A. | Chopra, S.

DSM-265. Plasmodium falciparum dihydroorotate dehydrogenase (PfDHODH) inhibitor, Treatment of malaria

enthalten in: Drugs of the future | 2019

von Thakare, R. | Kapoor, E. | Dasgupta, A. | +1

Ibrexafungerp. 1,3-Beta-Glucan synthase inhibitor, Triterpenoid antifungal agent

enthalten in: Drugs of the future | 2019

von Thakare, R. | Dasgupta, A. | Chopra, S.

Oteseconazole. Fungal lanosterol 14alpha-demethylase (CYP51) inhibitor, Treatment of recurrent vulvovaginal candidiasis, Treatment of onychomycosis

enthalten in: Drugs of the future | 2019

von Thakare, R. | Dasgupta, A. | Chopra, S.

Zoliflodacin. DNA gyrase subunit B (GyrB) (bacterial) inhibitor, Treatment of uncomplicated gonorrhea

enthalten in: Drugs of the future | 2019

von Thakare, R. | Dasgupta, A. | Chopra, S.

Murepavadin. Outer membrane protein-targeting antibiotic, Inhibitor of LptD-mediated lipopolysaccharide (LPS) transport, Treatment of Pseudomonas aeruginosa respiratory infections

enthalten in: Drugs of the future | 2018

von Chopra, S. | Thakare, R. | Dasgupta, A.

AQ-13. Aminoquinoline derivative, Treatment of malaria

enthalten in: Drugs of the future | 2018

von Thakare, R. | Dasgupta, A. | Chopra, S.

Cefiderocol. Inhibitor of penicillin-binding protein 3 (PBP3), Inhibitor of cell wall synthesis, Treatment of Gram-negative bacterial infections

enthalten in: Drugs of the future | 2017

von Thakare, R. | Chopra, S. | Dasgupta, A.